Risk Management



BEOVU potential risk to the fetus

There are two BEOVU forms:

Use BEOVU for all adult patients receiving Beovu.

Ask women of child-bearing age to also sign BEOVU.Possible risk for the fetus.

The BEOVU prescribing label states that there is a possible risk to the fetus from this and other anti-VEGF drugs.

It should only be used in women of childbearing age if the possible benefit for the woman is greater than the potential risk to the fetus.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Supporting your specialty.

OMIC was founded by members of the American Academy of Ophthalmology nearly a quarter century ago and is the only carrier sponsored and endorsed by AAO. OMIC is also endorsed by 54 other ophthalmic societies. The OMIC partnerships with state and subspecialty societies qualifies their members for an exclusive 10% premium credit. Contact your state society for details.

61864684